Novo Nordisk manufactures medicines for diabetes, including NovoLog, a rapid-acting insulin designed to help adults and children manage mealtime blood sugar. Its NovoCare program pairs the company’s diabetes products with education, insurance guidance, and affordability support, while NovoLog is offered in delivery formats ranging from pens to vials and insulin pumps.